Serine proteases profiles of Leishmania (Viannia) braziliensis clinical isolates with distinct susceptibilities to antimony

Glucantime (Sb(V)) is the first-line treatment against American Tegumentary Leishmaniasis. Resistance cases to this drug have been reported and related to host characteristics and parasite phenotypes. In this study, 12 Leishmania (Viannia) braziliensis isolates from patients that presented clinical...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Zabala-Peñafiel, Anabel, Dias-Lopes, Geovane, Cysne-Finkelstein, Léa, Conceição-Silva, Fátima, Miranda, Luciana de Freitas Campos, Fagundes, Aline, Schubach, Armando de Oliveira, Fernandes Pimentel, Maria Inês, Souza-Silva, Franklin, Machado, Lucas de Almeida, Alves, Carlos Roberto
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8271011/
https://ncbi.nlm.nih.gov/pubmed/34244581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-93665-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars